Advanced Search
AN Juan, PAN Yuanming, KANG Qian, WANG Xin, SUN Wei, YAN Yupeng, ZHENG Wei. Expression and Clinical Significance of miR-181d in Serum and PDCD4 in Gastric Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 131-137. DOI: 10.3971/j.issn.1000-8578.2019.18.0486
Citation: AN Juan, PAN Yuanming, KANG Qian, WANG Xin, SUN Wei, YAN Yupeng, ZHENG Wei. Expression and Clinical Significance of miR-181d in Serum and PDCD4 in Gastric Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 131-137. DOI: 10.3971/j.issn.1000-8578.2019.18.0486

Expression and Clinical Significance of miR-181d in Serum and PDCD4 in Gastric Cancer Patients

More Information
  • Received Date: April 12, 2018
  • Revised Date: October 29, 2018
  • Available Online: January 12, 2024
  • Objective 

    To investigate miR-181d and PDCD4 expression in the serum of gastric cancer(GC) patients and regulatory mechanism.

    Methods 

    The expression of miR-181d and PDCD4 were detected in 6 gastric cell lines using Real-time PCR and Western blot. Real-time PCR was used to detect miR-181d expression in serum of 58 GC patients and 50 healthy volunteers, and the protein level of PDCD4 was detected by ELISA assay. Furthermore, the experiment of siRNA or mimics was used to evaluate the role of miR-181d on the regulation of PDCD4 in GC cells, and we constructed the PDCD4 3'-UTR luciferase report vector to analyze the association between miR-181d and PDCD4.

    Results 

    miR-181d and PDCD4 were differentially expressed in GC cell lines; miR-181d in the serum of GC patients was higher than that in normal group (P < 0.001), while the expression of PDCD4 protein in GC patients was decreased (P < 0.05). It was found that there was a significant inverse correlation between miR-181d and PDCD4 expression in GC patients (R2=-0.44) and also in normal group(R2=-0.426). ROC curve analysis showed that miR-181d and PDCD4 had good specificity and sensitivity for the diagnosis of GC and normal population in vitro. Moreover, miR-181d expression was associated with smoking and drinking history, respectively (P=0.015, P=0.034). The expression of PDCD4 was only associated with drinking history(P < 0.001). Overexpression of miR-181d in AGS cells decreased the expression of PDCD4, and the expression of PDCD4 was increased after transfection with antisense miR-181d in BGC823 cells. Luciferase reporter system results suggested that miR-181d could bind to the 3'-UTR region of PDCD4.

    Conclusion 

    Elevated miR-181d expression and downregulated PDCD4 expression are detected in the serum of GC patients; miR-181d may mediate PDCD4 expression in the development of gastric cancer.

  • [1]
    Zhao JD, Geng PL, Li ZQ, et al.Associations between interleukin-1 polymorphisms and gastric cancers among three ethnicities[J].World J Gastroenterol, 2012, 18(47):7093-9. doi: 10.3748/wjg.v18.i47.7093
    [2]
    Jing JJ, Liu HY, Hao JK, et al.Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010[J].World J Gastroenterol, 2012, 18(11):1262-9. doi: 10.3748/wjg.v18.i11.1262
    [3]
    An J, Pan Y, Yan Z, et al.MiR-23a in amplified 19p13.13 loci targets Metallothionein 2A and promotes growth in gastric cancer cells[J].J Cell Biochem, 2013, 114(9):2160-9. doi: 10.1002/jcb.24565
    [4]
    Kim VN, Nam JW.Genomics of microRNA[J].Trends Genet, 2006, 22(3):165-73. http://d.old.wanfangdata.com.cn/OAPaper/oai_doaj-articles_8a8cfb38e0605a0fe63fb86961ec506c
    [5]
    Bartel DP.MicroRNAs:genomics, biogenesis, mechanism, and function[J].Cell, 2004, 116(2):281-97. doi: 10.1016/S0092-8674(04)00045-5
    [6]
    Malumbres R, Sarosiek KA, Cubedo E, et al.Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas[J].Blood, 2009, 113(16):3754-64. doi: 10.1182/blood-2008-10-184077
    [7]
    Pan Y, Xing R, An J, et al.Amplification of the miR-181c/d cluster is inversely correlated with PDCD4 expression in gastric cancer[J].Science Bulletin, 2014, 59(19):2240-8. doi: 10.1007/s11434-014-0280-z
    [8]
    李雅楠, 郝玉宾, 张志, 等.实时荧光定量PCR相对定量法检测循环miRNA的内参选择[J].生物技术通讯, 2015, 26(1):146-8. doi: 10.3969/j.issn.1009-0002.2015.01.032

    Li YN, Hao YB, Zhang Z, et al.Selection of Endogenous Reference Gene for RT-qPCR Analysis of Circulating microRNA Levels[J].Sheng Wu Ji Shu Tong Xun, 2015, 26(1):146-8. doi: 10.3969/j.issn.1009-0002.2015.01.032
    [9]
    Schwarzenbach H, Nishida N, Calin GA, et al.Clinical relevance of circulating cell-free microRNAs in cancer[J].Nat Rev Clin Oncol, 2014, 11(3):145-56. doi: 10.1038/nrclinonc.2014.5
    [10]
    Kroh EM, Parkin RK, Mitchell PS, et al.Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)[J].Methods, 2010, 50(4):298-301. doi: 10.1016/j.ymeth.2010.01.032
    [11]
    Rotkrua P, Shimada S, Mogushi K, et al.Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model[J].Br J Cancer, 2013, 108(4):932-40. doi: 10.1038/bjc.2013.30
    [12]
    Song MY, Pan KF, Su HJ, et al.Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer[J].PLoS One, 2012, 7(3):e33608. doi: 10.1371/journal.pone.0033608
    [13]
    Wang B, Hsu SH, Majumder S, et al.TGF beta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3[J].Oncogene, 2010, 29(12):1787-97. doi: 10.1038/onc.2009.468
    [14]
    Bloomston M, Frankel WL, Petrocca F, et al.MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis[J].JAMA, 2007, 297(17):1901-8. doi: 10.1001/jama.297.17.1901
    [15]
    Wang YT, Bai YF, Hu HT.Effect of miR181d on chemo-sensitivity in human small cell lung cancer[J].Chin J Chin Oncol, 2015, (6):345-50. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=zgzllc201506008
    [16]
    Li D, Shi M, Ji H, et al.MicroRNA-181d is a tumor suppressor in human esophageal squamous cell carcinoma inversely regulating Derlin-1[J].Oncol Rep, 2016, 36(4):2041-8. doi: 10.3892/or.2016.5028
    [17]
    Strotbek M, Schmid S, Sánchez-González I, et al.miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer[J].Int J Cancer, 2017, 140(10):2310-20. doi: 10.1002/ijc.v140.10
    [18]
    Yang F, Liu X, Liu Y, et al.miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma[J].Cancer Lett, 2017, 396:1-9. doi: 10.1016/j.canlet.2017.03.002
    [19]
    Zhang G, Liu D, Long G, et al.Downregulation of microRNA-181d had suppressive effect on pancreatic cancer development through inverse regulation of KNAIN2[J].Tumour Biol, 2017, 39(4):1010428317698364. http://cn.bing.com/academic/profile?id=48bd1fa460948e99b3ed0692f62d09d5&encoded=0&v=paper_preview&mkt=zh-cn

Catalog

    Article views (1400) PDF downloads (344) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return